INKT - MiNK Therapeutics GAAP EPS of -$0.18 August, 09 2022 08:07 AM MiNK Therapeutics Inc. MiNK Therapeutics press release ( NASDAQ: INKT ): Q2 GAAP EPS of -$0.18. The company ended the second quarter 2022 with a cash balance of $29.8 million as compared to $38.9 million at December 31, 2021. For further details see: MiNK Therapeutics GAAP EPS of -$0.18